Adage Capital Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-19,610
| Closed | -$5.36M | – | 880 |
|
|
2024
Q2 | $5.36M | Sell |
19,610
-900
| -4% | -$246K | 0.01% | 706 |
|
|
2024
Q1 | $7.09M | Buy |
20,510
+200
| +1% | +$69.2K | 0.01% | 655 |
|
|
2023
Q4 | $6.56M | Buy |
20,310
+19,500
| +2,407% | +$6.3M | 0.01% | 656 |
|
|
2023
Q3 | $290K | Sell |
810
-20,500
| -96% | -$7.35M | ﹤0.01% | 791 |
|
|
2023
Q2 | $8.08M | Sell |
21,310
-9,765
| -31% | -$3.7M | 0.02% | 603 |
|
|
2023
Q1 | $14.9M | Sell |
31,075
-400
| -1% | -$192K | 0.03% | 512 |
|
|
2022
Q4 | $13.2M | Sell |
31,475
-39,900
| -56% | -$16.8M | 0.03% | 560 |
|
|
2022
Q3 | $29.8M | Sell |
71,375
-30,700
| -30% | -$12.8M | 0.07% | 296 |
|
|
2022
Q2 | $50.5M | Buy |
102,075
+34,900
| +52% | +$17.3M | 0.12% | 184 |
|
|
2022
Q1 | $37.8M | Buy |
67,175
+44,165
| +192% | +$24.9M | 0.07% | 286 |
|
|
2021
Q4 | $17.4M | Sell |
23,010
-100
| -0.4% | -$75.6K | 0.03% | 521 |
|
|
2021
Q3 | $17.2M | Sell |
23,110
-300
| -1% | -$224K | 0.03% | 518 |
|
|
2021
Q2 | $15.1M | Sell |
23,410
-210
| -0.9% | -$135K | 0.03% | 564 |
|
|
2021
Q1 | $13.5M | Buy |
23,620
+230
| +1% | +$131K | 0.03% | 585 |
|
|
2020
Q4 | $13.6M | Sell |
23,390
-610
| -3% | -$356K | 0.03% | 524 |
|
|
2020
Q3 | $12.4M | Buy |
24,000
+18,200
| +314% | +$9.38M | 0.03% | 491 |
|
|
2020
Q2 | $2.62M | Buy |
+5,800
| New | +$2.62M | 0.01% | 671 |
|
|
2018
Q4 | – | Sell |
-90,000
| Closed | -$28.2M | – | 711 |
|
|
2018
Q3 | $28.2M | Buy |
90,000
+10,000
| +13% | +$3.13M | 0.06% | 330 |
|
|
2018
Q2 | $23.1M | Buy |
80,000
+5,000
| +7% | +$1.44M | 0.05% | 371 |
|
|
2018
Q1 | $18.8M | Sell |
75,000
-18,500
| -20% | -$4.63M | 0.04% | 409 |
|
|
2017
Q4 | $22.3M | Sell |
93,500
-6,500
| -7% | -$1.55M | 0.05% | 382 |
|
|
2017
Q3 | $22.2M | Buy |
100,000
+49,978
| +100% | +$11.1M | 0.05% | 389 |
|
|
2017
Q2 | $11.3M | Buy |
+50,022
| New | +$11.3M | 0.03% | 545 |
|